Drug Shortage Report for CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV
Report ID | 8489 |
Drug Identification Number | 02228556 |
Brand name | CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV |
Common or Proper name | Cholografin |
Company Name | BRACCO IMAGING CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MEGLUMINE IODIPAMIDE |
Strength(s) | 52% |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 10X20ml |
ATC code | V08AC |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-05-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-20 |
Company comments | This product is under review by the company's Marketing team as the demand has been very low over the last 7 years |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11065 BOUL. L-H LAFONTAINE VILLE D'ANJOU, QUEBEC CANADA H1J 2Z4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-08-01 | English | Compare |
v6 | 2017-05-02 | English | Compare |
v5 | 2017-05-01 | French | Compare |
v4 | 2017-05-01 | English | Compare |
v3 | 2017-05-01 | English | Compare |
v2 | 2017-05-01 | English | Compare |
v1 | 2017-05-01 | English | Compare |
Showing 1 to 7 of 7